AXIS Clinicals Goes Global
6/6/2013 9:03:14 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Hyderabad, Jan. 15, 2013: AXIS Clinicals Group, a leading Clinical Research Organization (CRO) announces the commencement of it’s operations at Mexico. With this facility, AXIS Clinicals Group now has three centers spread in India & overseas and can offer clinical research solutions to global clients. This new center is the largest CRO facility in Mexico with bio-analytical and reference labs all housed in the same building that is spread over 4000 sq meters. The Mexico center is a 100-bed clinical facility that can grow to 160-beds and has over 50 employees with eight doctors all recruited from prestigious local universities. Over 300 methods have been developed on a global basis including hormonal, oncology and biotechnological products. Separate ambulatory area and sampling area with reclining reposers are also some of the key facilities at the centre. It is the only CRO facility in Northern Mexico City with a database of 5000 healthy volunteers, thus minimizing risk of cross participation. It has received the COFEPRIS license approval in record time and has four LCMS machines in its bio-analytical division with a capacity to go up to 15 LCMS. The centre is equipped to handle phase II-IV studies and has a database of 2000 investigators. It has already been contracted for 75 studies from multinational, big pharma clientele as well as large local Mexican laboratories. It is an active member of AMETA - Mexican CRO Industry Association.
About AXIS Clinicals
AXIS Clinicals Limited, one of India’s leading CRO is committed to serving the biopharmaceutical industry by leveraging two powerful trends impacting the world of Clinical Research - globalisation and full spectrum offering. Established in September 2004, the company has completed over 1500 clinical studies, 300 ANDA studies and received 50 product approvals from regulatory agencies. The company facilities have been accredited by DCGI (Drugs Controller General, India), NABL (National Accreditation Board for Testing and Calibration Laboratories - ISO 15189:2003) and inspected by US-FDA, UK-MHRA, Brazil-ANVISA and France AFSSAPS and conforms to ICH and CDSCO-GCP & GLP Guidelines.
For further details, please visit – www.axisclinicals.com
Help employers find you! Check out all the jobs and post your resume.
comments powered by